These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 9833802)

  • 21. Reproductive factors and risk of breast cancer: A Review.
    Kapil U; Bhadoria AS; Sareen N; Singh P; Dwivedi SN
    Indian J Cancer; 2014; 51(4):571-6. PubMed ID: 26842199
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The relationship of estrogen and progesterone to breast disease.
    Brooks PG
    J Reprod Med; 1984 Jul; 29(7 Suppl):530-8. PubMed ID: 6481706
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Hormonal replacement therapy and breast cancer].
    This P
    Rev Prat; 2005 Feb; 55(4):377-82. PubMed ID: 15828615
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Oestrogens, progestins and breast proliferation.
    Thijssen JH
    Zentralbl Gynakol; 1997; 119 Suppl 2():43-7. PubMed ID: 9361394
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The connection between abortion and cancer of the breast: what all women in the world have a right to know].
    Servir; 2002; 50(3):124-8. PubMed ID: 12229029
    [No Abstract]   [Full Text] [Related]  

  • 26. Patients' perception of risk and breast cancer awareness.
    Baum M
    Br J Radiol; 1997 Aug; 70(836):777-81. PubMed ID: 9486039
    [No Abstract]   [Full Text] [Related]  

  • 27. Hormone replacement therapy in women with breast cancer. Do the risks outweigh the benefits?
    Roy JA; Sawka CA; Pritchard KI
    J Clin Oncol; 1996 Mar; 14(3):997-1006. PubMed ID: 8622051
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Female sex hormones increase the risk of breast cancer].
    Vatten L
    Tidsskr Nor Laegeforen; 1998 Aug; 118(19):2969-74. PubMed ID: 9748837
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tamoxifen, mammographic density, and breast cancer prevention.
    Boyd NF
    J Natl Cancer Inst; 2011 May; 103(9):704-5. PubMed ID: 21487099
    [No Abstract]   [Full Text] [Related]  

  • 30. Effects of hormone therapy on the endometrium.
    Deligdisch L
    Mod Pathol; 1993 Jan; 6(1):94-106. PubMed ID: 8426860
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hormones and breast cancer: evidence and implications for consideration of risks and benefits of hormone replacement therapy.
    Colditz GA
    J Womens Health; 1999 Apr; 8(3):347-57. PubMed ID: 10326989
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Letrozole vs. placebo after adjuvant tamoxifen in postmenopausal breast cancer. The example of the MA-17 study].
    Forciniti S
    Suppl Tumori; 2004; 3(4):S25-6. PubMed ID: 15206205
    [No Abstract]   [Full Text] [Related]  

  • 33. Selective estrogen receptor modulators and the combination therapy conjugated estrogens/bazedoxifene: A review of effects on the breast.
    Pickar JH; Komm BS
    Post Reprod Health; 2015 Sep; 21(3):112-21. PubMed ID: 26289836
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hormone therapy, mammographic density, and breast cancer risk.
    Martin LJ; Minkin S; Boyd NF
    Maturitas; 2009 Sep; 64(1):20-6. PubMed ID: 19709825
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Estrogen and estrogen plus progestin act directly on the mammary gland to increase proliferation in a postmenopausal mouse model.
    Raafat AM; Li S; Bennett JM; Hofseth LJ; Haslam SZ
    J Cell Physiol; 2001 Apr; 187(1):81-9. PubMed ID: 11241352
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Oestrogen and breast cancer.
    Snyder RD
    Med J Aust; 1992 Dec 7-21; 157(11-12):838-40. PubMed ID: 1454026
    [No Abstract]   [Full Text] [Related]  

  • 37. Effects of tamoxifen on steroid hormone receptors and hormone concentration and the results of DNA analysis by flow cytometry in endometrial carcinoma.
    Nola M; Jukić S; Ilić-Forko J; Babić D; Uzarević B; Petrovecki M; Suchanek E; Skrablin S; Dotlić S; Marusić M
    Gynecol Oncol; 1999 Mar; 72(3):331-6. PubMed ID: 10053103
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mammographic density, response to hormones, and breast cancer risk.
    Boyd NF; Melnichouk O; Martin LJ; Hislop G; Chiarelli AM; Yaffe MJ; Minkin S
    J Clin Oncol; 2011 Aug; 29(22):2985-92. PubMed ID: 21709206
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hormonal replacement therapy (HRT) in postmenopause: a reappraisal.
    Caufriez A
    Ann Endocrinol (Paris); 2007 Sep; 68(4):241-50. PubMed ID: 17651686
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Parallel assessment of the impact of different hormone replacement therapies on breast density by radiologist- and computer-based analyses of mammograms.
    Pettersen PC; Raundahl J; Loog M; Nielsen M; Tankó LB; Christiansen C
    Climacteric; 2008 Apr; 11(2):135-43. PubMed ID: 18365856
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.